Clinical Trials Browser

Phase 1 × INDUSTRY × GSK2879552 × Clear all

NCT02034123 2019-12-06

Investigation of GSK2879552 in Subjects With Relapsed/Refractory Small Cell Lung Carcinoma

Phase 1 Terminated

29 enrolled 34 charts

Neoplasms, Carcinoma, Small Cell, Small Cell Lung Carcinoma

NCT02177812 2019-06-28

A Phase I Dose Escalation Study of GSK2879552 in Subjects With Acute Myeloid Leukemia (AML)

Phase 1 Terminated

41 enrolled 34 charts

Other hematologic neoplasm

Leukemia, Neoplasms, Leukemia, Myeloid, Acute